HERTFORDSHIRE, England and
PITTSBURGH, Jan. 9, 2017 /PRNewswire/ -- Mylan N.V.
(NASDAQ, TASE: MYL) today announced that CEO Heather Bresch will present at the
35th Annual J.P. Morgan Healthcare Conference on Wednesday, Jan. 11, 2017, in San Francisco. The presentation is scheduled
to begin at 9:00 a.m. PST
(12:00 p.m. EST).
Interested parties can access a live webcast of the presentation
via the investor relations section of Mylan's Web site at
www.mylan.com/investors. An archived version will also be available
following the live presentation and can be accessed at the same
location for a limited time.
Mylan is a global pharmaceutical company committed to setting
new standards in healthcare. Working together around the world to
provide 7 billion people access to high quality medicine, we
innovate to satisfy unmet needs; make reliability and service
excellence a habit; do what's right, not what's easy; and impact
the future through passionate global leadership. We offer a growing
portfolio of more than 2,700 generic and branded pharmaceuticals,
including antiretroviral therapies on which approximately 50% of
people being treated for HIV/AIDS worldwide depend. We market our
products in more than 165 countries and territories. Our global
R&D and manufacturing platform includes more than 50
facilities, and we are one of the world's largest producers of
active pharmaceutical ingredients. Every member of our more than
35,000-strong workforce is dedicated to creating better health for
a better world, one person at a time. Learn more at mylan.com.
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/mylan-to-present-at-the-35th-annual-jp-morgan-healthcare-conference-300387657.html
SOURCE Mylan N.V.